Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 79, Issue 7
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Spondyloarthritis
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
Online download statistics by month:
Online download statistics by month: May 2020 to January 2021
Abstract
Full
Pdf
May 2020
1067
1039
475
Jun 2020
684
701
227
Jul 2020
339
333
166
Aug 2020
148
147
127
Sep 2020
147
140
85
Oct 2020
240
238
163
Nov 2020
243
237
192
Dec 2020
209
205
140
Jan 2021
150
144
99
Total
3227
3184
1674
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF